James LaCamp

CIK: 0001794194

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PETS

PETMED EXPRESS INC

Director

PHLT

Performant Healthcare Inc

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

PETS
PETMED EXPRESS INC
Aug 11, 2026
Award(A)
Direct
55.6K shares-
PETS
PETMED EXPRESS INC
Oct 30, 2025
Award(A)
Direct
34.9K shares-
PHLT
Performant Healthcare Inc
Oct 21, 2025
Disposition(D)
Direct
417.2K shares-
PHLT
Performant Healthcare Inc
Jul 28, 2025
Award(A)
Restricted Stock Units
Direct
35.6K shares-

		Type	Shares	Price		Ownership
Aug 11, 2026	PETS PETMED EXPRESS INC	Award(A)	55,555	-	$0	Direct
Oct 30, 2025	PETS PETMED EXPRESS INC	Award(A)	34,866	-	-	Direct
Oct 21, 2025	PHLT Performant Healthcare Inc	Disposition(D)	417,220	-	-	Direct
Jul 28, 2025	PHLT Performant Healthcare Inc	Award(A) Restricted Stock Units	35,616	-	-	Direct

1-4 of 4 transactions

About LaCamp James

LaCamp James (SEC CIK 0001794194) files insider reports with the SEC as Director of PETMED EXPRESS INC (PETS) and Director of Performant Healthcare Inc (PHLT).

Signal8 holds 5 ownership filings by LaCamp James (1 Form 3, 4 Form 4), filed between Jul 28, 2025 and Aug 12, 2026. Those filings report 4 transactions, from Jul 28, 2025 to Aug 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on LaCamp James's filings is in DELRAY BEACH, FL.

Recent filings by LaCamp James

Aug 11, 2026: Grant or award of PETS shares (Form 4, code A).
Oct 30, 2025: Grant or award of PETS shares (Form 4, code A).
Oct 21, 2025: Disposition to issuer transaction of PHLT shares (Form 4, code D).
Jul 28, 2025: Grant or award of PHLT derivative securities (Form 4, code A).

Other insiders filing for PETMED EXPRESS INC (PETS)

Willard Jeffrey Allen, CEO and President
Elkeles Tamar, Director
Campbell Leslie C.G., Interim CEO and President
Batushansky Peter, Director
Mennen Justin L., Director
KRULIK DOUGLAS, CAO and Interim CFO

How to read Form 4 transaction codes